Oligodendroglial fatty acid metabolism as a central nervous system energy reserve.


Journal

Nature neuroscience
ISSN: 1546-1726
Titre abrégé: Nat Neurosci
Pays: United States
ID NLM: 9809671

Informations de publication

Date de publication:
09 Sep 2024
Historique:
received: 22 06 2023
accepted: 05 08 2024
medline: 10 9 2024
pubmed: 10 9 2024
entrez: 9 9 2024
Statut: aheadofprint

Résumé

Brain function requires a constant supply of glucose. However, the brain has no known energy stores, except for glycogen granules in astrocytes. In the present study, we report that continuous oligodendroglial lipid metabolism provides an energy reserve in white matter tracts. In the isolated optic nerve from young adult mice of both sexes, oligodendrocytes survive glucose deprivation better than astrocytes. Under low glucose, both axonal ATP levels and action potentials become dependent on fatty acid β-oxidation. Importantly, ongoing oligodendroglial lipid degradation feeds rapidly into white matter energy metabolism. Although not supporting high-frequency spiking, fatty acid β-oxidation in mitochondria and oligodendroglial peroxisomes protects axons from conduction blocks when glucose is limiting. Disruption of the glucose transporter GLUT1 expression in oligodendrocytes of adult mice perturbs myelin homeostasis in vivo and causes gradual demyelination without behavioral signs. This further suggests that the imbalance of myelin synthesis and degradation can underlie myelin thinning in aging and disease.

Identifiants

pubmed: 39251890
doi: 10.1038/s41593-024-01749-6
pii: 10.1038/s41593-024-01749-6
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Deutsche Forschungsgemeinschaft (German Research Foundation)
ID : SPP1757
Organisme : Deutsche Forschungsgemeinschaft (German Research Foundation)
ID : TRR-274

Informations de copyright

© 2024. The Author(s).

Références

Cohen, C. C. et al. Saltatory conduction along myelinated axons involves a periaxonal nanocircuit. Cell 180, 311–322.e315 (2020).
pubmed: 31883793 pmcid: 6978798 doi: 10.1016/j.cell.2019.11.039
Fünfschilling, U. et al. Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity. Nature 485, 517–521 (2012).
pubmed: 22622581 pmcid: 3613737 doi: 10.1038/nature11007
Lee, Y. et al. Oligodendroglia metabolically support axons and contribute to neurodegeneration. Nature 487, 443–448 (2012).
pubmed: 22801498 pmcid: 3408792 doi: 10.1038/nature11314
Saab, A. S. et al. Oligodendroglial NMDA receptors regulate glucose import and axonal energy metabolism. Neuron 91, 119–132 (2016).
pubmed: 27292539 pmcid: 9084537 doi: 10.1016/j.neuron.2016.05.016
Trevisiol, A. et al. Monitoring ATP dynamics in electrically active white matter tracts. eLife 6, e24241 (2017).
pubmed: 28414271 pmcid: 5415357 doi: 10.7554/eLife.24241
Schirmeier, S., Matzat, T. & Klämbt, C. Axon ensheathment and metabolic supply by glial cells in Drosophila. Brain Res. 1641, 122–129 (2016).
pubmed: 26367447 doi: 10.1016/j.brainres.2015.09.003
Rey, S., Zalc, B. & Klämbt, C. Evolution of glial wrapping: a new hypothesis. Dev. Neurobiol. 81, 453–463 (2021).
pubmed: 32133794 doi: 10.1002/dneu.22739
Weil, M.-T. et al. Axonal ensheathment in the nervous system of lamprey: implications for the evolution of myelinating glia. J. Neurosci. 38, 6586–6596 (2018).
pubmed: 29941446 pmcid: 6705951 doi: 10.1523/JNEUROSCI.1034-18.2018
Silva, B. et al. Glia fuel neurons with locally synthesized ketone bodies to sustain memory under starvation. Nat. Metab. 4, 213–224 (2022).
pubmed: 35177854 pmcid: 8885408 doi: 10.1038/s42255-022-00528-6
Nave, K.-A., Tzvetanova, I. D. & Schirmeier, S. Glial cell evolution: the origins of a lipid store. Cell Metab. 26, 701–702 (2017).
pubmed: 29117544 doi: 10.1016/j.cmet.2017.10.011
Meschkat, M. et al. White matter integrity in mice requires continuous myelin synthesis at the inner tongue. Nat. Commun. 13, 1163 (2022).
pubmed: 35246535 pmcid: 8897471 doi: 10.1038/s41467-022-28720-y
Toyama, B. H. et al. Identification of long-lived proteins reveals exceptional stability of essential cellular structures. Cell 154, 971–982 (2013).
pubmed: 23993091 pmcid: 3788602 doi: 10.1016/j.cell.2013.07.037
Ando, S., Tanaka, Y., Toyoda, Y. & Kon, K. Turnover of myelin lipids in aging brain. Neurochem. Res. 28, 5–13 (2003).
pubmed: 12587659 doi: 10.1023/A:1021635826032
Richert, S. et al. In vivo labeling of peroxisomes by photoconvertible mEos2 in myelinating glia of mice. Biochimie 98, 127–134 (2014).
pubmed: 24262602 doi: 10.1016/j.biochi.2013.10.022
Williams, N. C. & O’Neill, L. A. A role for the Krebs cycle intermediate citrate in metabolic reprogramming in innate immunity and inflammation. Front. Immunol. 9, 141 (2018).
pubmed: 29459863 pmcid: 5807345 doi: 10.3389/fimmu.2018.00141
Kolb, H. et al. Ketone bodies: from enemy to friend and guardian angel. BMC Med. 19, 313 (2021).
pubmed: 34879839 pmcid: 8656040 doi: 10.1186/s12916-021-02185-0
Cunnane, S. C. et al. Brain energy rescue: an emerging therapeutic concept for neurodegenerative disorders of ageing. Nat. Rev. Drug Discov. 19, 609–633 (2020).
pubmed: 32709961 pmcid: 7948516 doi: 10.1038/s41573-020-0072-x
Shin, M., Asada, S., Mizumori, N., Sano, K. & Umezawa, C. Effect of thioridazine or chlorpromazine on increased hepatic NAD
pubmed: 9625489 doi: 10.1111/j.2042-7158.1998.tb06884.x
Aber, E. R. et al. Oligodendroglial macroautophagy is essential for myelin sheath turnover to prevent neurodegeneration and death. Cell Rep. 41, 111480 (2022).
pubmed: 36261002 pmcid: 9639605 doi: 10.1016/j.celrep.2022.111480
Weil, M. T. et al. Loss of myelin basic protein function triggers myelin breakdown in models of demyelinating diseases. Cell Rep. 16, 314–322 (2016).
pubmed: 27346352 pmcid: 4949381 doi: 10.1016/j.celrep.2016.06.008
Coleman, M. P. & Hoke, A. Programmed axon degeneration: from mouse to mechanism to medicine. Nat. Rev. Neurosci. 21, 183–196 (2020).
pubmed: 32152523 pmcid: 8926152 doi: 10.1038/s41583-020-0269-3
Shaw, G. et al. Uman-type neurofilament light antibodies are effective reagents for the imaging of neurodegeneration. Brain Commun. 5, fcad067 (2023).
pubmed: 37091583 pmcid: 10120172 doi: 10.1093/braincomms/fcad067
Oliva Trejo, J. A. et al. Characterization of starvation-induced autophagy in cerebellar Purkinje cells of pHluorin-mKate2-human LC3B transgenic mice. Sci. Rep. 10, 9643 (2020).
pubmed: 32541814 pmcid: 7295967 doi: 10.1038/s41598-020-66370-6
Zhou, C. et al. Monitoring autophagic flux by an improved tandem fluorescent-tagged LC3 (mTagRFP-mWasabi-LC3) reveals that high-dose rapamycin impairs autophagic flux in cancer cells. Autophagy 8, 1215–1226 (2012).
pubmed: 22647982 doi: 10.4161/auto.20284
Ioannou, M. S. et al. Neuron-astrocyte metabolic coupling protects against activity-induced fatty acid toxicity. Cell 177, 1522–1535.e1514 (2019).
pubmed: 31130380 doi: 10.1016/j.cell.2019.04.001
Ferreira, G. C. & McKenna, M. C. L-Carnitine and acetyl-L-carnitine roles and neuroprotection in developing brain. Neurochem. Res. 42, 1661–1675 (2017).
pubmed: 28508995 pmcid: 5621476 doi: 10.1007/s11064-017-2288-7
Verheijden, S. et al. Peroxisomal multifunctional protein-2 deficiency causes neuroinflammation and degeneration of Purkinje cells independent of very long chain fatty acid accumulation. Neurobiol. Dis. 58, 258–269 (2013).
pubmed: 23777740 doi: 10.1016/j.nbd.2013.06.006
Settembre, C. et al. TFEB links autophagy to lysosomal biogenesis. Science 332, 1429–1433 (2011).
pubmed: 21617040 pmcid: 3638014 doi: 10.1126/science.1204592
Sun, L. O. et al. Spatiotemporal control of CNS myelination by oligodendrocyte programmed cell death through the TFEB-PUMA axis. Cell 175, 1811–1826.e1821 (2018).
pubmed: 30503207 pmcid: 6295215 doi: 10.1016/j.cell.2018.10.044
Falcao, A. M. et al. Disease-specific oligodendrocyte lineage cells arise in multiple sclerosis. Nat. Med. 24, 1837–1844 (2018).
pubmed: 30420755 pmcid: 6544508 doi: 10.1038/s41591-018-0236-y
Czopka, T. & Lyons, D. A. Individual oligodendrocytes have only a few hours in which to generate new myelin sheaths in vivo. Dev. Cell 25, 599–609 (2013).
pubmed: 23806617 pmcid: 4013507 doi: 10.1016/j.devcel.2013.05.013
Snaidero, N. et al. Myelin membrane wrapping of CNS axons by PI(3,4,5)P3-dependent polarized growth at the inner tongue. Cell 156, 277–290 (2014).
pubmed: 24439382 pmcid: 4862569 doi: 10.1016/j.cell.2013.11.044
Zhou, X. et al. Mature myelin maintenance requires Qki to coactivate PPARβ-RXRα–mediated lipid metabolism. J. Clin. Invest. 130, 2220–2236 (2020).
pubmed: 32202512 pmcid: 7191000 doi: 10.1172/JCI131800
Wiggins, R. C., Miller, S. L., Benjamins, J. A., Krigman, M. R. & Morell, P. Myelin synthesis during postnatal nutritional deprivation and subsequent rehabilitation. Brain Res. 107, 257–273 (1976).
pubmed: 1268727 doi: 10.1016/0006-8993(76)90225-0
Smith, M. E. The metabolism of myelin lipids. Adv. Lipid Res. 5, 241–278 (1967).
pubmed: 4866074 doi: 10.1016/B978-1-4831-9941-2.50013-3
Geelen, M., Lopes-Cardozo, M. & Edmond, J. Acetoacetate: a major substrate for the synthesis of cholesterol and fatty acids by isolated rat hepatocytes. FEBS Lett. 163, 269–273 (1983).
pubmed: 6641943 doi: 10.1016/0014-5793(83)80833-3
Auestad, N., Korsak, R. A., Morrow, J. W. & Edmond, J. Fatty acid oxidation and ketogenesis by astrocytes in primary culture. J. Neurochem. 56, 1376–1386 (1991).
pubmed: 2002348 doi: 10.1111/j.1471-4159.1991.tb11435.x
McMullen, E. et al. Glycolytically impaired Drosophila glial cells fuel neural metabolism via β-oxidation. Nat. Commun. 14, 2996 (2023).
pubmed: 37225684 pmcid: 10209077 doi: 10.1038/s41467-023-38813-x
Klosinski, L. P. et al. White matter lipids as a ketogenic fuel supply in aging female brain: implications for Alzheimer’s disease. eBioMedicine 2, 1888–1904 (2015).
pubmed: 26844268 pmcid: 4703712 doi: 10.1016/j.ebiom.2015.11.002
Halestrap, A. P. & PRICE, N. T. The proton-linked monocarboxylate transporter (MCT) family: structure, function and regulation. Biochem. J. 343, 281–299 (1999).
pubmed: 10510291 pmcid: 1220552 doi: 10.1042/bj3430281
Giaume, C., Naus, C. C., Sáez, J. C. & Leybaert, L. Glial connexins and pannexins in the healthy and diseased brain. Physiol. Rev. 101, 93–145 (2021).
pubmed: 32326824 doi: 10.1152/physrev.00043.2018
Philips, T. et al. MCT1 deletion in oligodendrocyte lineage cells causes late-onset hypomyelination and axonal degeneration. Cell Rep. 34, 108610 (2021).
pubmed: 33440165 pmcid: 8020895 doi: 10.1016/j.celrep.2020.108610
Papadopoulos, M. C., Koumenis, I. L., Dugan, L. L. & Giffard, R. G. Vulnerability to glucose deprivation injury correlates with glutathione levels in astrocytes. Brain Res. 748, 151–156 (1997).
pubmed: 9067456 doi: 10.1016/S0006-8993(96)01293-0
Brown, A. M., Wender, R. & Ransom, B. R. Metabolic substrates other than glucose support axon function in central white matter. J. Neurosci. Res. 66, 839–843 (2001).
pubmed: 11746409 doi: 10.1002/jnr.10081
Wender, R. et al. Astrocytic glycogen influences axon function and survival during glucose deprivation in central white matter. J. Neurosci. 20, 6804–6810 (2000).
pubmed: 10995824 pmcid: 6772835 doi: 10.1523/JNEUROSCI.20-18-06804.2000
Gerdts, J., Summers, D. W., Milbrandt, J. & DiAntonio, A. Axon self-destruction: new links among SARM1, MAPKs, and NAD
pubmed: 26844829 pmcid: 4742785 doi: 10.1016/j.neuron.2015.12.023
Dubois, R. Variations du glycogene du foie et du sucre du sang et du foie dans l’état de veille et dans l’état de torpeur, chez la marmotte et de influence des nerfs pneumogastriques et sympathetiques sur le sucre du sang et du foie pendant le passage de la torpeur à l’état de veille. Compt. Rendu. Soc. Biol. 64, 219–220 (1894).
Lyman, C. P. & Chatfield, P. O. Physiology of hibernation in mammals. Physiol. Rev. 35, 403–425 (1955).
pubmed: 14384514 doi: 10.1152/physrev.1955.35.2.403
Blaker, W. D. & Moscatelli, E. A. The effect of hibernation on the lipids of brain myelin and microsomes in the Syrian hamster. J. Neurochem. 31, 1513–1518 (1978).
pubmed: 551129 doi: 10.1111/j.1471-4159.1978.tb06578.x
Kim, J. H. & Koh, S.-B. Extensive white matter injury in hypoglycemic coma. Neurology 68, 1074–1074 (2007).
pubmed: 17389314 doi: 10.1212/01.wnl.0000258546.83251.36
Nickel, K. et al. White matter abnormalities in the corpus callosum in acute and recovered anorexia nervosa patients—a diffusion tensor imaging study. Front. Psychiatry 10, 490 (2019).
pubmed: 31338044 pmcid: 6628864 doi: 10.3389/fpsyt.2019.00490
Pappaianni, E. et al. Initial evidence of abnormal brain plasticity in anorexia nervosa: an ultra-high field study. Sci. Rep. 12, 2589 (2022).
pubmed: 35173174 pmcid: 8850617 doi: 10.1038/s41598-022-06113-x
Koffman, B. M., Greenfield, L. J., Ali, I. I. & Pirzada, N. A. Neurologic complications after surgery for obesity. Muscle Nerve 33, 166–176 (2006).
pubmed: 15973660 doi: 10.1002/mus.20394
Collins, G. H., Webster, H. D. F. & Victor, M. The ultrastructure of myelin and axonal alterations in sciatic nerves of thiamine deficient and chronically starved rats. Acta Neuropathol. 3, 511–521 (1964).
pubmed: 14192316 doi: 10.1007/BF00688459
Bouçanova, F. & Chrast, R. Metabolic interaction between Schwann cells and axons under physiological and disease conditions. Front. Cell. Neurosci. 14, 148 (2020).
pubmed: 32547370 pmcid: 7274022 doi: 10.3389/fncel.2020.00148
Bergaglio, T., Luchicchi, A. & Schenk, G. J. Engine failure in axo-myelinic signaling: a potential key player in the pathogenesis of multiple sclerosis. Front. Cell. Neurosci. 15, 610295 (2021).
pubmed: 33642995 pmcid: 7902503 doi: 10.3389/fncel.2021.610295
Ihara, M. et al. Quantification of myelin loss in frontal lobe white matter in vascular dementia, Alzheimer’s disease, and dementia with Lewy bodies. Acta Neuropathol. 119, 579–589 (2010).
pubmed: 20091409 pmcid: 2849937 doi: 10.1007/s00401-009-0635-8
Jackson, J. et al. White matter tauopathy: transient functional loss and novel myelin remodeling. Glia 66, 813–827 (2018).
pubmed: 29315804 doi: 10.1002/glia.23286
Roy, M. et al. Fascicle-and glucose-specific deterioration in white matter energy supply in Alzheimer’s disease. J. Alzheimer’s Dis. 76, 863–881 (2020).
doi: 10.3233/JAD-200213
Regenold, W. T. et al. Myelin staining of deep white matter in the dorsolateral prefrontal cortex in schizophrenia, bipolar disorder, and unipolar major depression. Psychiatry Res. 151, 179–188 (2007).
pubmed: 17433451 doi: 10.1016/j.psychres.2006.12.019
Nave, K.-A. & Ehrenreich, H. Myelination and oligodendrocyte functions in psychiatric diseases. JAMA Psychiatry 71, 582–584 (2014).
pubmed: 24671770 doi: 10.1001/jamapsychiatry.2014.189
Heintz, N. Gene expression nervous system atlas (GENSAT). Nat. Neurosci. 7, 483–483 (2004).
pubmed: 15114362 doi: 10.1038/nn0504-483
Jung, S. et al. Analysis of fractalkine receptor CX3CR1 function by targeted deletion and green fluorescent protein reporter gene insertion. Mol. Cell. Biol. 20, 4106–4114 (2000).
pubmed: 10805752 pmcid: 85780 doi: 10.1128/MCB.20.11.4106-4114.2000
Karram, K. et al. NG2‐expressing cells in the nervous system revealed by the NG2‐EYFP‐knockin mouse. Genesis 46, 743–757 (2008).
pubmed: 18924152 doi: 10.1002/dvg.20440
Lappe-Siefke, C. et al. Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination. Nat. Genet. 33, 366–374 (2003).
pubmed: 12590258 doi: 10.1038/ng1095
Young, C. D. et al. Modulation of glucose transporter 1 (GLUT1) expression levels alters mouse mammary tumor cell growth in vitro and in vivo. PLoS ONE 6, e23205 (2011).
pubmed: 21826239 pmcid: 3149640 doi: 10.1371/journal.pone.0023205
Doerflinger, N. H., Macklin, W. B. & Popko, B. Inducible site‐specific recombination in myelinating cells. Genesis 35, 63–72 (2003).
pubmed: 12481300 doi: 10.1002/gene.10154
Olowe, Y. & Schulz, H. 4-Bromocrotonic acid, an effective inhibitor of fatty acid oxidation and ketone body degradation in rat heart mitochondria. On the rate-determining step of beta-oxidation and ketone body degradation in heart. J. Biol. Chem. 257, 5408–5413 (1982).
pubmed: 7068598 doi: 10.1016/S0021-9258(19)83791-2
Raud, B. et al. Etomoxir actions on regulatory and memory T cells are independent of Cpt1a-mediated fatty acid oxidation. Cell Metab. 28, 504–515.e507 (2018).
pubmed: 30043753 pmcid: 6747686 doi: 10.1016/j.cmet.2018.06.002
Orr, A. L. et al. Suppressors of superoxide production from mitochondrial complex III. Nat. Chem. Biol. 11, 834–836 (2015).
pubmed: 26368590 pmcid: 4618194 doi: 10.1038/nchembio.1910
Dikalova, A. E. et al. Therapeutic targeting of mitochondrial superoxide in hypertension. Circ. Res. 107, 106–116 (2010).
pubmed: 20448215 pmcid: 2901409 doi: 10.1161/CIRCRESAHA.109.214601
Amaravadi, R. K. & Winkler, J. D. Lys05: a new lysosomal autophagy inhibitor. Autophagy 8, 1383–1384 (2012).
pubmed: 22878685 pmcid: 3442884 doi: 10.4161/auto.20958
Chen, G. et al. 3, 4‐Dimethoxychalcone induces autophagy through activation of the transcription factors TFE 3 and TFEB. EMBO Mol. Med. 11, e10469 (2019).
pubmed: 31609086 pmcid: 6835206 doi: 10.15252/emmm.201910469
Erwig, M. S. et al. Anillin facilitates septin assembly to prevent pathological outfoldings of central nervous system myelin. eLife 8, e43888 (2019).
pubmed: 30672734 pmcid: 6344079 doi: 10.7554/eLife.43888
Siems, S. B. et al. Proteome profile of peripheral myelin in healthy mice and in a neuropathy model. eLife 9, e51406 (2020).
pubmed: 32130108 pmcid: 7056269 doi: 10.7554/eLife.51406
Berghoff, S. A. et al. Blood-brain barrier hyperpermeability precedes demyelination in the cuprizone model. Acta Neuropathol. Commun. 5, 94 (2017).
pubmed: 29195512 pmcid: 5710130 doi: 10.1186/s40478-017-0497-6
Stumpf, S. K. et al. Ketogenic diet ameliorates axonal defects and promotes myelination in Pelizaeus–Merzbacher disease. Acta Neuropathol. 138, 147–161 (2019).
pubmed: 30919030 pmcid: 6570703 doi: 10.1007/s00401-019-01985-2
Ghandour, M. et al. Immunochemical and immunohistochemical study of carbonic anhydrase II in adult rat cerebellum: a marker for oligodendrocytes. Neuroscience 5, 559–571 (1980).
pubmed: 6769072 doi: 10.1016/0306-4522(80)90053-6
Sørensen, B. K. et al. Silver staining of proteins on electroblotting membranes and intensification of silver staining of proteins separated by polyacrylamide gel electrophoresis. Anal. Biochem. 304, 33–41 (2002).
pubmed: 11969186 doi: 10.1006/abio.2001.5604
Silva, J. C., Gorenstein, M. V., Li, G.-Z., Vissers, J. P. & Geromanos, S. J. Absolute quantification of proteins by LCMSE: a virtue of parallel MS acquisition. Mol. Cell. Proteomics 5, 144–156 (2006).
pubmed: 16219938 doi: 10.1074/mcp.M500230-MCP200
Distler, U. et al. Drift time-specific collision energies enable deep-coverage data-independent acquisition proteomics. Nat. Methods 11, 167–170 (2014).
pubmed: 24336358 doi: 10.1038/nmeth.2767
Jahn, O. et al. The CNS myelin proteome: deep profile and persistence after post-mortem delay. Front. Cell. Neurosci. 14, 239 (2020).
pubmed: 32973451 pmcid: 7466725 doi: 10.3389/fncel.2020.00239
Ambrozkiewicz, M. C. et al. Polarity acquisition in cortical neurons is driven by synergistic action of Sox9-regulated Wwp1 and Wwp2 E3 ubiquitin ligases and intronic miR-140. Neuron 100, 1097–1115.e15 (2018).
pubmed: 30392800 doi: 10.1016/j.neuron.2018.10.008
Weil, M.-T., Ruhwedel, T., Meschkat, M., Sadowski, B. & Möbius, W. Transmission electron microscopy of oligodendrocytes and myelin. Methods Mol. Biol. 1936, 343–375 (2019).
pubmed: 30820909 doi: 10.1007/978-1-4939-9072-6_20
Stys, P. K., Ransom, B. R. & Waxman, S. G. Compound action potential of nerve recorded by suction electrode: a theoretical and experimental analysis. Brain Res. 546, 18–32 (1991).
pubmed: 1855148 doi: 10.1016/0006-8993(91)91154-S
Trevisiol, A. et al. Structural myelin defects are associated with low axonal ATP levels but rapid recovery from energy deprivation in a mouse model of spastic paraplegia. PLoS Biol. 18, e3000943 (2020).
pubmed: 33196637 pmcid: 7704050 doi: 10.1371/journal.pbio.3000943
Kleinecke, S. et al. Peroxisomal dysfunctions cause lysosomal storage and axonal Kv1 channel redistribution in peripheral neuropathy. eLife https://doi.org/10.7554/eLife.23332 (2017).
Perez-Riverol, Y. et al. The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences. Nucleic Acids Res. 50, D543–D552 (2022).
pubmed: 34723319 doi: 10.1093/nar/gkab1038

Auteurs

Ebrahim Asadollahi (E)

Max Planck Institute for Multidisciplinary Sciences, Department of Neurogenetics, Göttingen, Germany. asadollahi@mpinat.mpg.de.

Andrea Trevisiol (A)

Max Planck Institute for Multidisciplinary Sciences, Department of Neurogenetics, Göttingen, Germany.
University of Toronto, Sunnybrook Health Sciences Centre, Department of Physical Sciences, North York, Ontario, Canada.

Aiman S Saab (AS)

Max Planck Institute for Multidisciplinary Sciences, Department of Neurogenetics, Göttingen, Germany.
University of Zurich, Institute of Pharmacology and Toxicology, Zurich, Switzerland.

Zoe J Looser (ZJ)

University of Zurich, Institute of Pharmacology and Toxicology, Zurich, Switzerland.

Payam Dibaj (P)

Max Planck Institute for Multidisciplinary Sciences, Department of Neurogenetics, Göttingen, Germany.
Center for Rare Diseases Göttingen, Department of Pediatrics and Pediatric Neurology, Georg August University Göttingen, Göttingen, Germany.

Reyhane Ebrahimi (R)

Max Planck Institute for Multidisciplinary Sciences, Department of Neurogenetics, Göttingen, Germany.

Kathrin Kusch (K)

Max Planck Institute for Multidisciplinary Sciences, Department of Neurogenetics, Göttingen, Germany.
University of Göttingen Medical School, Institute for Auditory Neuroscience and Inner Ear Lab, Göttingen, Germany.

Torben Ruhwedel (T)

Max Planck Institute for Multidisciplinary Sciences, Department of Neurogenetics, Göttingen, Germany.

Wiebke Möbius (W)

Max Planck Institute for Multidisciplinary Sciences, Department of Neurogenetics, Göttingen, Germany.

Olaf Jahn (O)

Max Planck Institute for Multidisciplinary Sciences, Department of Molecular Neurobiology, Neuroproteomics Group, Göttingen, Germany.
University Medical Center Göttingen, Department of Psychiatry and Psychotherapy, Translational Neuroproteomics Group, Göttingen, Germany.

Jun Yup Lee (JY)

School of Medical Sciences and Charles Perkins Centre, The University of Sydney, Camperdown, New South Wales, Australia.

Anthony S Don (AS)

School of Medical Sciences and Charles Perkins Centre, The University of Sydney, Camperdown, New South Wales, Australia.

Michelle-Amirah Khalil (MA)

Department for Bioinformatics and Biochemistry, Braunschweig Integrated Center of System Biology, Technische Universität Braunschweig, Braunschweig, Germany.

Karsten Hiller (K)

Department for Bioinformatics and Biochemistry, Braunschweig Integrated Center of System Biology, Technische Universität Braunschweig, Braunschweig, Germany.

Myriam Baes (M)

Lab of Cell Metabolism, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium.

Bruno Weber (B)

University of Zurich, Institute of Pharmacology and Toxicology, Zurich, Switzerland.

E Dale Abel (ED)

Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.

Andrea Balabio (A)

Telethon Institute of Genetics and Medicine, Naples, Italy.
Department of Translational Medical Sciences, Federico II University, Naples, Italy.
Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA.
Jan and Dan Duncan Neurological Research Institute, Texas Children's Hospital, Houston, TX, USA.

Brian Popko (B)

Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.

Celia M Kassmann (CM)

Max Planck Institute for Multidisciplinary Sciences, Department of Neurogenetics, Göttingen, Germany.

Hannelore Ehrenreich (H)

Max Planck Institute for Multidisciplinary Sciences, Clinical Neuroscience, Göttingen, Germany.
Central Institute of Mental Health, Mannheim, Germany.

Johannes Hirrlinger (J)

Max Planck Institute for Multidisciplinary Sciences, Department of Neurogenetics, Göttingen, Germany.
Carl-Ludwig-Institute for Physiology, Faculty of Medicine, University of Leipzig, Leipzig, Germany.

Klaus-Armin Nave (KA)

Max Planck Institute for Multidisciplinary Sciences, Department of Neurogenetics, Göttingen, Germany. nave@mpinat.mpg.de.

Classifications MeSH